MedTrace Logo

Analysis of Sexual Bias in Type 2 Innate Lymphoid Cells (ILC2) in Asthmatic Patients

NCT04384835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2023-06-01

No results posted yet for this study

Summary

Asthma is more common in females than in males but the difference has not been explained yet. Group 2 innate lymphoid cells (ILC2) have recently emerged as critical players in the initiation of allergic responses but their implications in the difference between males and females in terms of asthma prevalence has not been fully studied. The aim of this project is to compare the proportion of ILC2 in blood between males and females with asthma.

Conditions

Interventions

BIOLOGICAL

Blood sample collection (one tube)

Collection of one tube of 7.5 ml blood in addition to a blood sample made in clinical practice

BIOLOGICAL

Blood sample collection (five tubes)

Collection of five tubes of 7.5 ml blood in addition to a blood sample made in clinical practice

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Laurent Guilleminault, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-05-01
Completion
2023-04-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384835 on ClinicalTrials.gov